Siemens enters long-term distributor agreement

Article

As part of an aggressive strategy to expand its marketing reach in North America, Siemens has contracted with Cassling Diagnostic Imaging to sell its products and services to customers in Nebraska, Iowa, Kansas, South Dakota, and west central Illinois.

As part of an aggressive strategy to expand its marketing reach in North America, Siemens has contracted with Cassling Diagnostic Imaging to sell its products and services to customers in Nebraska, Iowa, Kansas, South Dakota, and west central Illinois. CDI will have access to all Siemens imaging products and services. The agreement extends the existing relationship between the two companies through which CDI sells several Siemens products, including mammography and mobile x-ray systems (SCAN 2/16/2000). Siemens will train CDI’s sales personnel, service engineers, and other employees.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.